Welcome to the CIMT Annual Meeting, Europe's largest meeting focused on cancer immunotherapy research and development.
The Association for Cancer Immunotherapy CIMT is a member-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. Since 2003, the CIMT Annual Meeting has connected the global cancer immunotherapy community in the heart of Europe. As the largest science-driven, not-for-profit event in Europe on cancer immunology and immunotherapy, CIMT invites international participants for high-level scientific exchange, collaboration and discussion focused on cancer immunotherapy.

For more information on the Association for Cancer Immunotherapy, please go to www.cimt.eu

The CIMT Annual Meeting will take place at
Rheingoldhalle Congress Center

Rheinstraße 66
55116 Mainz, Germany
Venue information

Meeting OverviewFacts and Numbers

2023 Annual Meeting Program Committee

Andrew Kaiser
Mainz, Germany
Markus Maeurer
Champalimaud Foundation and Botton-Champalimaud Pancreatic Cancer Center
Lisbon, Portugal
Robbert Van der Most
Mainz, Germany
Sine Reker Hadrup
Techncal University of Denmark
Copenhagen, Denmark
Harpreet Singh
Tübingen, Germany
Yardena Samuels
Weizmann Institute of Science
Rehovot Israel
Mustafa Diken
CIMT Scientific Program Director; TRON-Translational Oncology
Mainz, Germany
Johanna Olweus
Oslo University Hospital
Oslo, Norway

The 2023 Annual Meeting is supported by


CIMT is committed to complying with the codes of practice governing the interactions between the industry and healthcare professionals and organizations. For this reason, all companies and associations exhibiting at CIMT are advised to consult the guidelines and codes of practice applicable in Germany. By signing the relevant application form, each company or organization agrees to and confirms that it has reviewed the advice and guidelines which determine the applicable codes of practice in Germany, and that it will adhere to all relevant codes and will accept full liability for all cases of non-compliance with these codes.
The 20th CIMT Annual Meeting is an Ethical MedTech compliant event. www.ethicalmedtech.eu.‍

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development